Sieuwerts, Anieta M <br/><br/>
Which cyclin E prevails as prognostic marker for breast cancer? Results from a retrospective study involving 635 lymph node-negative breast cancer patients.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Jun 2006 
 - 3319-28 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1078-0432 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-06-0225  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Biomarkers, Tumor--genetics<br/>Breast Neoplasms--diagnosis<br/>Cyclin E--genetics<br/>Cyclins--genetics<br/>Disease-Free Survival<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Middle Aged<br/>Multivariate Analysis<br/>Oncogene Proteins--genetics<br/>Predictive Value of Tests<br/>Prognosis<br/>RNA, Messenger--genetics<br/>Retrospective Studies<br/>Reverse Transcriptase Polymerase Chain Reaction--methods